Article Versions Notes

Nair AB, Shah J, Al-Dhubiab BE, Jacob S, Patel SS, Venugopala KN, Morsy MA, Gupta S, Attimarad M, Sreeharsha N, et al. Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics. 2021; 13(4):523. https://doi.org/10.3390/pharmaceutics13040523

Nair, Anroop B., Jigar Shah, Bandar E. Al-Dhubiab, Shery Jacob, Snehal S. Patel, Katharigatta N. Venugopala, Mohamed A. Morsy, Sumeet Gupta, Mahesh Attimarad, Nagaraja Sreeharsha, and et al. 2021. "Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies" Pharmaceutics 13, no. 4: 523. https://doi.org/10.3390/pharmaceutics13040523

Nair, A. B., Shah, J., Al-Dhubiab, B. E., Jacob, S., Patel, S. S., Venugopala, K. N., Morsy, M. A., Gupta, S., Attimarad, M., Sreeharsha, N., & Shinu, P. (2021). Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics, 13(4), 523. https://doi.org/10.3390/pharmaceutics13040523